Reuters logo
BRIEF-Wuyi International Pharmaceutical says HY revenue RMB 38 mln
August 30, 2017 / 10:50 PM / a month ago

BRIEF-Wuyi International Pharmaceutical says HY revenue RMB 38 mln

Aug 31 (Reuters) - Wuyi International Pharmaceutical Co Ltd

* Hy revenue rmb 38.0 million versus rmb 171.5 million

* Hy loss for period attributable rmb 493.497 million versus loss of rmb 159.104 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below